Analysis | Samples | Factors | Units |
---|---|---|---|
HILIC POSITIVE ION MODE | P_3D7_MIPS2571_1 | cell_type:iRBC | treatment:3D7 + Compound 3-1 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_MIPS2571_2 | cell_type:iRBC | treatment:3D7 + Compound 3-2 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_MIPS2571_3 | cell_type:iRBC | treatment:3D7 + Compound 3-3 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_gluc_1 | cell_type:iRBC | treatment:3D7 + Glucosamine -1 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_gluc_2 | cell_type:iRBC | treatment:3D7 + Glucosamine -2 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_gluc_3 | cell_type:iRBC | treatment:3D7 + Glucosamine -3 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_1 | cell_type:iRBC | treatment:DMSO -1 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_2 | cell_type:iRBC | treatment:DMSO -2 | relative intensity |
HILIC POSITIVE ION MODE | P_3D7_3 | cell_type:iRBC | treatment:DMSO -3 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_1 | cell_type:iRBC | treatment:PfAM17-HAglmS-1 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_2 | cell_type:iRBC | treatment:PfAM17-HAglmS-2 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_3 | cell_type:iRBC | treatment:PfAM17-HAglmS-3 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_gluc_1 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -1 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_gluc_2 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -2 | relative intensity |
HILIC POSITIVE ION MODE | P_2E7_gluc_3 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -3 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_MIPS2571_1 | cell_type:iRBC | treatment:3D7 + Compound 3-1 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_MIPS2571_2 | cell_type:iRBC | treatment:3D7 + Compound 3-2 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_MIPS2571_3 | cell_type:iRBC | treatment:3D7 + Compound 3-3 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_gluc_1 | cell_type:iRBC | treatment:3D7 + Glucosamine -1 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_gluc_2 | cell_type:iRBC | treatment:3D7 + Glucosamine -2 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_gluc_3 | cell_type:iRBC | treatment:3D7 + Glucosamine -3 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_1 | cell_type:iRBC | treatment:DMSO -1 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_2 | cell_type:iRBC | treatment:DMSO -2 | relative intensity |
HILIC NEGATIVE ION MODE | P_3D7_3 | cell_type:iRBC | treatment:DMSO -3 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_1 | cell_type:iRBC | treatment:PfAM17-HAglmS-1 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_2 | cell_type:iRBC | treatment:PfAM17-HAglmS-2 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_3 | cell_type:iRBC | treatment:PfAM17-HAglmS-3 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_gluc_1 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -1 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_gluc_2 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -2 | relative intensity |
HILIC NEGATIVE ION MODE | P_2E7_gluc_3 | cell_type:iRBC | treatment:PfAM17-HAglmS +Glucosamine -3 | relative intensity |